Galderma Group N Strategic Asset Allocation Index
Galderma Group N strategic asset allocation index. Galderma Group N (GALD) has a Strategic Asset Allocation Index of 8.7% as of June 2025. Strategic assets (PP&E of CHF672.00 Million plus long-term investments of CHF-) total CHF672.00 Million, measured against net assets of CHF7.73 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Galderma Group N tangible equity quality to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Galderma Group N (2022–2024)
Strategic asset allocation index of Galderma Group N from 2022 to 2024. This chart shows how Galderma Group N's Strategic Asset Allocation Index has evolved across 3 annual periods from 2022 to 2024. As of June 2025, the index stands at 8.7%, representing strategic assets of CHF672.00 Million against net assets of CHF7.73 Billion CHF.
Galderma Group N Strategic Asset Allocation Index by Year (2022–2024)
Galderma Group N strategic asset allocation index by year from 2022 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Galderma Group N from 2022 to 2024, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Galderma Group N stock valuation.
| Year | SAAI | Strategic Assets (CHF) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 7.4% | CHF577.00 Million | CHF577.00 Million | CHF- | CHF7.79 Billion | ▼ -4.3 pp |
| 2023 | 11.7% | CHF529.20 Million | CHF529.20 Million | CHF- | CHF4.52 Billion | ▲ +2.0 pp |
| 2022 | 9.7% | CHF400.80 Million | CHF400.80 Million | CHF- | CHF4.13 Billion | — |